Candriam S.C.A. Has $2.46 Million Holdings in AMETEK, Inc. $AME

Key Points

• Candriam S.C.A. reduced its stake in AMETEK, Inc. by 14.8%, owning 14,295 shares worth approximately $2.46 million after selling 2,475 shares.
• AMETEK received varied analyst ratings, with seven analysts giving it a "Buy" rating and an average price target set at $208.00.
• The company reported earnings per share of $1.78 for the last quarter, exceeding analyst expectations and marking a 2.5% revenue increase year-over-year.

Candriam S.C.A. reduced its position in AMETEK, Inc. (NYSE:AME - Free Report) by 14.8% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 14,295 shares of the technology company's stock after selling 2,475 shares during the quarter. Candriam S.C.A.'s holdings in AMETEK were worth $2,461,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Olde Wealth Management LLC bought a new stake in AMETEK in the first quarter valued at about $29,000. Annis Gardner Whiting Capital Advisors LLC boosted its holdings in shares of AMETEK by 57.7% in the 1st quarter. Annis Gardner Whiting Capital Advisors LLC now owns 194 shares of the technology company's stock valued at $33,000 after buying an additional 71 shares during the period. Banque Transatlantique SA bought a new stake in shares of AMETEK during the 4th quarter valued at about $37,000. Minot DeBlois Advisors LLC bought a new stake in shares of AMETEK during the 4th quarter valued at about $43,000. Finally, Zions Bancorporation National Association UT bought a new stake in shares of AMETEK during the 1st quarter valued at about $42,000. 87.43% of the stock is owned by institutional investors.

AMETEK Price Performance

NYSE AME traded down $0.04 on Wednesday, reaching $186.74. 1,049,293 shares of the stock traded hands, compared to its average volume of 1,370,183. The firm's fifty day simple moving average is $181.44 and its 200 day simple moving average is $177.02. The company has a quick ratio of 1.04, a current ratio of 1.63 and a debt-to-equity ratio of 0.15. The company has a market cap of $43.13 billion, a price-to-earnings ratio of 30.07, a P/E/G ratio of 2.67 and a beta of 1.10. AMETEK, Inc. has a 12 month low of $145.02 and a 12 month high of $198.33.

AMETEK (NYSE:AME - Get Free Report) last issued its quarterly earnings results on Thursday, July 31st. The technology company reported $1.78 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.69 by $0.09. The firm had revenue of $1.78 billion during the quarter, compared to analyst estimates of $1.74 billion. AMETEK had a return on equity of 16.53% and a net margin of 20.60%.The firm's quarterly revenue was up 2.5% on a year-over-year basis. During the same period last year, the company posted $1.66 EPS. AMETEK has set its Q3 2025 guidance at 1.720-1.760 EPS. FY 2025 guidance at 7.060-7.200 EPS. As a group, research analysts predict that AMETEK, Inc. will post 7.15 EPS for the current fiscal year.

AMETEK Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 30th. Stockholders of record on Monday, September 15th will be given a dividend of $0.31 per share. This represents a $1.24 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date is Monday, September 15th. AMETEK's dividend payout ratio is 19.97%.

Wall Street Analyst Weigh In

AME has been the subject of a number of recent research reports. Morgan Stanley boosted their price objective on shares of AMETEK from $185.00 to $198.00 and gave the company an "equal weight" rating in a research report on Friday, August 8th. DA Davidson boosted their price objective on shares of AMETEK from $210.00 to $215.00 and gave the company a "buy" rating in a research report on Friday, August 1st. Truist Financial boosted their price objective on shares of AMETEK from $196.00 to $200.00 and gave the company a "buy" rating in a research report on Monday, May 5th. Melius lowered shares of AMETEK from a "buy" rating to a "hold" rating and set a $192.00 target price for the company. in a research note on Monday, July 14th. Finally, Robert W. Baird lifted their price target on AMETEK from $190.00 to $198.00 and gave the company a "neutral" rating in a report on Monday, August 4th. Seven equities research analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of "Hold" and a consensus target price of $208.00.

AMETEK Profile

AMETEK, Inc manufactures and sells electronic instruments and electromechanical devices in the North America, Europe, Asia, and South America, and internationally. The company's EIG segment offers advanced instruments for the process, aerospace, power, and industrial markets; process and analytical instruments for the oil and gas, petrochemical, pharmaceutical, semiconductor, automation, and food and beverage industries; instruments to the laboratory equipment, ultra-precision manufacturing, medical, and test and measurement markets; power quality monitoring and c devices, uninterruptible power supplies, programmable power and electromagnetic compatibility test equipment, and sensors for gas turbines and dashboard instruments; heavy trucks, instrumentation, and controls for the food and beverage industries; and aircraft and engine sensors, power supplies, embedded computing, monitoring, fuel and fluid measurement, and data acquisition systems for aerospace and defense industry.